Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.455,79
0,18%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seelos Therapeutics Inc (SEEL) Seelos Therapeutics Inc (SEEL) Notizie

SEEL

Seelos Therapeutics (SEEL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SEEL
DataOraFonteTitoloSimboloCompagnia
05/06/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
31/05/202422:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
20/05/202422:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
14/05/202414:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202423:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202422:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
01/03/202423:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
06/02/202423:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
02/02/202412:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
02/01/202414:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
28/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
18/12/202322:54Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
15/12/202322:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
04/12/202322:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
28/11/202322:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SEELSeelos Therapeutics Inc
29/06/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
12/05/202322:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SEELSeelos Therapeutics Inc
28/04/202312:23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202322:11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202323:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202322:09Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SEELSeelos Therapeutics Inc
13/03/202321:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SEELSeelos Therapeutics Inc
10/03/202312:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SEELSeelos Therapeutics Inc
09/02/202318:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
08/07/202222:59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SEELSeelos Therapeutics Inc
04/05/202213:35TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Masimo (MASI)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202223:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SEELSeelos Therapeutics Inc
11/03/202218:05TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Leap Therapeutics (LPTX)NASDAQ:SEELSeelos Therapeutics Inc
24/01/202210:50TipRanksB.Riley Financial Thinks Seelos Therapeutics’ Stock is Going to RecoverNASDAQ:SEELSeelos Therapeutics Inc
27/12/202123:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SEELSeelos Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SEEL

La tua Cronologia

BIT
UV8CJ1
UniCredit Bank
COIN
INVOXUSD
Invox Finance Token
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network